Momelotinib Outperforms Danocrine in Myelofibrosis Symptom Management 🔗 Access full article via CureTodayMomelotinib led to symptom, spleen and anemia benefits for patients with previously treated myelofibrosis, according to updated study findings. Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
